6 investors discuss why AI is more than just a buzzword in biotech
TechCrunch
DECEMBER 15, 2022
The survey also covers the implications of U.S Boston Consulting Group (BCG) partner Chris Meier reported in the March 22 Issue of Nature Reviews Drug Discovery that 24 “AI native” drug discovery companies have a combined 160 disclosed discovery programs. How has due diligence in this space changed in 2022?
Let's personalize your content